Search Results 81-90 of 13587 for direct bilirubin

1. Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment-Naïve Mantle Cell Lymphoma - Mayo Clinic

   Total bilirubin < 2.0 X ULN (unless active hemolysis); for subjects with Gilbert's Syndrome, direct bilirubin < 1.5 X ULN. Patients with known infection ...

2. A Study To Investigate Mepolizumab In The Treatment Of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

   ... Bilirubin ≤ 1.5x ULN (isolated bilirubin>1.5x ULN is acceptable if bilirubin is fractionated and direct bilirubin <35%); Other laboratory parameter ...

3. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma - Mayo Clinic

   Total bilirubin ≤ 1.5 times upper limit of normal (ULN). For total bilirubin > 1.5 times ULN, the direct bilirubin must be normal. Alkaline phosphatase ≤ 3 ...

4. Addition Of Daratumumab To Combination Of Bortezomib And Dexamethasone In Participants With Relapsed Or Refractory Multiple Myeloma - Mayo Clinic

   Total bilirubin level ≥ 1.5 × ULN, (except for Gilbert Syndrome: direct bilirubin 1.5 × ULN);; Creatinine clearance ≤ 20 mL/min/1.73 m2 (may be calculated ...

5. A Randomized Study Of Olaparib Or Placebo In Patients With Surgically Removed Pancreatic Cancer Who Have A BRCA1, BRCA2 Or PALB2 Mutation, The APOLLO Trial - Mayo Clinic

   Patients with Gilbert's syndrome may enroll if direct bilirubin ≤ 2.5 ULN of the direct bilirubin (obtained ≤ 14 days prior to randomization). Aspartate ...

6. Study Of DISC-0974 (RALLY-MF) In Participants With Myelofibrosis Or Myelodysplastic Syndrome And Anemia - Mayo Clinic

   Direct bilirubin <2x ULN at Screening. Higher levels are acceptable if these can be attributed by the Investigator to ineffective erythropoiesis or ...

7. A Study Of Obesity And Inflammation Impact Immunotherapy For Renal Cancer - Mayo Clinic

   ... bilirubin within normal laboratory limits (≤1.5 times the upper limit of normality [≤2.0 in patients with known Gilbert's syndrome] OR direct bilirubin ...

8. A Study Comparing The Efficacy, Safety And Tolerability Of Fixed Dose Combination (FDC) Of FF/UMEC/VI With The FDC Of FF/VI And UMEC/VI; Administered Once-daily Via A Dry Powder Inhaler (DPI) In Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

   ... bilirubin <=1.5xULN (isolated bilirubin >1.5 x ULN is acceptable if bilirubin is fractionated and direct bilirubin <35%); French subjects: In France, a ...

9. A Phase I/II, Open-label, Multi-center Trial Of [177Lu]Lu-NeoB In Combination With Capecitabine In Adult Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression On Previous Endocrine Therapy In Combination With A CDK4/6 Inhibito - Mayo Clinic

   ... bilirubin is ≤ 3.0 × ULN or direct bilirubin ≤ 1.5 × ULN;. In absence of liver metastases, alanine aminotransferase (ALT) and aspartate aminotransferase ...

10. A Study To Investigate The Effectiveness And Safety Of Pf-04965842 In Subjects Aged 12 Years And Over, With Moderate To Severe Atopic Dermatitis With The Option Of Rescue Treatment In Flaring Subjects - Mayo Clinic

    ... direct bilirubin measured and would be eligible for this study provided the direct bilirubin is ≤ ULN. In the opinion of the investigator or sponsor, have ...